Myriad Genetics (MYGN) Change in Taxes (2010 - 2026)

Myriad Genetics (MYGN) has reported Change in Taxes for 17 consecutive years, with -$10.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Taxes fell 376.19% year-over-year to -$10.0 million; the TTM figure through Mar 2026 stood at -$12.3 million (down 207.5% YoY), while the FY2025 annual figure was -$4.4 million, down 780.0% from the prior year.
• Change in Taxes fell to -$10.0 million in Q1 2026 per MYGN's latest filing, from -$1.8 million in the prior quarter.
• Across five years, Change in Taxes topped out at $1.4 million in Q1 2024 and bottomed at -$10.0 million in Q1 2026.
• Historically, Change in Taxes has averaged -$1.2 million across 5 years, with a median of -$500000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Taxes soared 100.44% — and 2026, when it slumped 376.19%.
• Myriad Genetics' Change in Taxes stood at -$200000.0 in 2022, then slumped by 150.0% to -$500000.0 in 2023, then slipped by 20.0% to -$600000.0 in 2024, then slumped by 200.0% to -$1.8 million in 2025, then tumbled by 455.56% to -$10.0 million in 2026.
• Business Quant data shows MYGN's Change in Taxes at -$10.0 million in Q1 2026, -$1.8 million in Q4 2025, and -$500000.0 in Q3 2025.